![Tsuyoshi Okuno](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Tsuyoshi Okuno worked as a Senior Manager at Mitsubishi Tanabe Pharma Corp.
from 2002 to 2019, and as a Director at MP Healthcare Venture Management, Inc. from 2019 to 2023.
He received his undergraduate degree from Osaka University in 2000, and his graduate degrees, including an MBA and a doctorate, from Osaka Prefecture University in 2017.
Anciens postes connus de Tsuyoshi Okuno
| Sociétés | Poste | Fin |
|---|---|---|
MP Healthcare Venture Management, Inc.
 MP Healthcare Venture Management, Inc. Investment ManagersFinance MP Healthcare Venture invests in companies located in the North America and Europe. The firm focuses on sectors such as biotechnology, biopharmaceuticals, therapeutics and diagnostics. It participates in seed and early stage capital transactions. | Private Equity Investor | 02/07/2023 |
| MITSUBISHI TANABE PHARMA CORPORATION | Private Equity Investor | 01/07/2019 |
Formation de Tsuyoshi Okuno
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
30
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Mitsubishi Tanabe Pharma Corp.
 Mitsubishi Tanabe Pharma Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical products | Health Technology |
Osaka University
 Osaka University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Osaka Prefecture University
 Osaka Prefecture University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MP Healthcare Venture Management, Inc.
MP Healthcare Venture Management, Inc. Investment ManagersFinance MP Healthcare Venture invests in companies located in the North America and Europe. The firm focuses on sectors such as biotechnology, biopharmaceuticals, therapeutics and diagnostics. It participates in seed and early stage capital transactions. | Finance |
Choisissez Zonebourse 
